The landscape of blood sugar treatment is advancing with the emergence of transdermal GLP-1 delivery . These innovative devices offer a possibly more comfortable alternative to injections for individuals dealing with diabetes 2. They deliver glucagon-like peptide-1 directly through the epidermis,